These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 14965236)
1. New antipsychotics and schizophrenia: a review on efficacy and side effects. Serretti A; De Ronchi D; Lorenzi C; Berardi D Curr Med Chem; 2004 Feb; 11(3):343-58. PubMed ID: 14965236 [TBL] [Abstract][Full Text] [Related]
2. Quetiapine versus other atypical antipsychotics for schizophrenia. Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315 [TBL] [Abstract][Full Text] [Related]
3. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics. Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652 [TBL] [Abstract][Full Text] [Related]
4. Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions. Raggi MA; Mandrioli R; Sabbioni C; Pucci V Curr Med Chem; 2004 Feb; 11(3):279-96. PubMed ID: 14965232 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. McEvoy JP; Lieberman JA; Stroup TS; Davis SM; Meltzer HY; Rosenheck RA; Swartz MS; Perkins DO; Keefe RS; Davis CE; Severe J; Hsiao JK; Am J Psychiatry; 2006 Apr; 163(4):600-10. PubMed ID: 16585434 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. Stroup TS; Lieberman JA; McEvoy JP; Swartz MS; Davis SM; Rosenheck RA; Perkins DO; Keefe RS; Davis CE; Severe J; Hsiao JK; Am J Psychiatry; 2006 Apr; 163(4):611-22. PubMed ID: 16585435 [TBL] [Abstract][Full Text] [Related]
7. [Current pharmacotherapy of schizophrenia]. Bitter I Orv Hetil; 2004 Jan; 145(3):105-9. PubMed ID: 15027331 [TBL] [Abstract][Full Text] [Related]
8. Ziprasidone: a new atypical antipsychotic. Keck PE; McElroy SL; Arnold LM Expert Opin Pharmacother; 2001 Jun; 2(6):1033-42. PubMed ID: 11585006 [TBL] [Abstract][Full Text] [Related]
9. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine. Tada M; Shirakawa K; Matsuoka N; Mutoh S Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255 [TBL] [Abstract][Full Text] [Related]
10. Use of atypical antipsychotics in mood disorders. Weizman R; Weizman A Curr Opin Investig Drugs; 2001 Jul; 2(7):940-5. PubMed ID: 11757795 [TBL] [Abstract][Full Text] [Related]
11. A model of anticholinergic activity of atypical antipsychotic medications. Chew ML; Mulsant BH; Pollock BG; Lehman ME; Greenspan A; Kirshner MA; Bies RR; Kapur S; Gharabawi G Schizophr Res; 2006 Dec; 88(1-3):63-72. PubMed ID: 16928430 [TBL] [Abstract][Full Text] [Related]
12. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
13. Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses. Zedkova I; Dudova I; Urbanek T; Hrdlicka M Neuro Endocrinol Lett; 2011; 32(5):667-70. PubMed ID: 22167144 [TBL] [Abstract][Full Text] [Related]
14. One-year, randomized, open trial comparing olanzapine, quetiapine, risperidone and ziprasidone effectiveness in antipsychotic-naive patients with a first-episode psychosis. San L; Arranz B; Perez V; Safont G; Corripio I; Ramirez N; Dueñas R; Alvarez E Psychiatry Res; 2012 Dec; 200(2-3):693-701. PubMed ID: 22954905 [TBL] [Abstract][Full Text] [Related]
15. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia. Keck PE; Strakowski SM; McElroy SL J Clin Psychiatry; 2000; 61 Suppl 3():4-9. PubMed ID: 10724127 [TBL] [Abstract][Full Text] [Related]
16. Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia. Kinon BJ; Liu-Seifert H; Adams DH; Citrome L J Clin Psychopharmacol; 2006 Dec; 26(6):632-7. PubMed ID: 17110821 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. Lieberman JA; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Keefe RS; Davis SM; Davis CE; Lebowitz BD; Severe J; Hsiao JK; N Engl J Med; 2005 Sep; 353(12):1209-23. PubMed ID: 16172203 [TBL] [Abstract][Full Text] [Related]
18. Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: a pragmatic, randomized trial. Johnsen E; Jørgensen HA; Kroken RA; Løberg EM Eur Psychiatry; 2013 Mar; 28(3):174-84. PubMed ID: 22153730 [TBL] [Abstract][Full Text] [Related]
19. Comparing the side effect profile of the atypical antipsychotics. Alao AO; Malhotra K; Dewan MJ West Afr J Med; 2002; 21(4):313-5. PubMed ID: 12665274 [TBL] [Abstract][Full Text] [Related]
20. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Kapur S; Remington G Annu Rev Med; 2001; 52():503-17. PubMed ID: 11160792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]